Safety, tolerability, and antibody response after intradermal vaccination of PFE-BNT in adults who have completed two-doses of Verocell (inactivated vaccine)
Introduction: The necessity for an equal distribution of the COVID-19 vaccination is critical. Lower-middle and lower income countries may not be able to manufacture their vaccines, nor may they be able to afford to buy them for every inhabitant. Furthermore, the vaccination's potency may wane...
Main Authors: | Nipon Chalermphanchai, Wachiraporn Arunothong, Niphawan Jettavan, Surin Chanta, Thunthiwa Boonpisitsakul, Monthon Mayoon, Piyawan Lueangchiranothai, Natthawat Yodsurang, Wichai Chanchue, Yupin Tananuchit, Kullaya Jangaroon, Waroonkarn Meungsuwan, Thantima Nantawong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-04-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136222000080 |
Similar Items
-
Myocarditis Following Inactivated SARS-CoV-2 Vaccine (Vero Cell) in an Adult Female in Vietnam: A Case Report
by: Tran H, et al.
Published: (2023-09-01) -
PfeIF4E and PfeIF4A colocalize and their double-stranded RNA inhibits Plasmodium falciparum proliferation
by: Renu Tuteja, et al.
Published: (2010-11-01) -
Primary failure of eruption (PFE): a systematic review
by: Marcel Hanisch, et al.
Published: (2018-03-01) -
Allocating risk in public infrastructure project provision via PFE
by: Md. Yusof, Aminah
Published: (2011) -
Primary failure of eruption (PFE) - a systematic literature review
by: Hubert Nieścior, et al.
Published: (2022-08-01)